title: Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent.
abstract: A comparison between in vitro and in vivo experiments conducted to investigate the acoustic properties of a novel, 1.2 microm diameter poly(lactic-co-glycolic acid) (50:50) (PLGA) ultrasound contrast agent, the development of which was described previously by us, is presented. A pulse-echo setup was used to determine enhancement in vitro. Additional in vitro studies further characterized the hollow microcapsules, including resonance frequency from attenuation measurements (from 2.25 to 15 MHz) and temperature effects (25 degrees C vs. 37 degrees C). In vivo, four rabbits received intravenous injections of the agent (dose range: 0.005-0.13 ml/kg). Quantitative in vivo dose-responses were calculated off-line using spectral power analysis of audio Doppler signals acquired from a custom-made 10 MHz cuff transducer placed around the surgically exposed distal aorta. This frequency was chosen since the very shallow scanning depths encountered in rabbits, in particular for the cuff transducer placed directly around the vessel, necessitates the use of high frequency imaging devices with sufficient spatial resolution to enable meaningful measurements. For qualitative assessments, two rabbits were imaged pre- and post-contrast administration (dose: 0.1 ml/kg) in power Doppler mode. Significant acoustic enhancements (up to 24 dB) were reported both in vitro and in vivo. Moreover, the rabbits did not show any adverse side effects from multiple injections (>20) of the agent. Measured in vitro resonance frequency between 3.09 and 3.49 MHz was lower than predicted for a similar sized free bubble, potentially due to capsule wall structure. Minimal loss of signal (approximately 4 dB) was observed at 25 degrees C over 20 min of insonation at 5 MHz but at 37 degrees C the signal dropped close to base line within the first 5 min. This temperature sensitivity could be due to loss of capsule integrity (and hence loss of gas). Potential causes include increased hydrolysis or polymer softening and increased water uptake by the shell at temperatures closer to the glass transition temperature (T(g)).
authors.affiliation: School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, USA. wheatley@coe.drexel.edu
authors.forename: Margaret A
authors.initials: MA
authors.lastname: Wheatley
authors.forename: Flemming
authors.initials: F
authors.lastname: Forsberg
authors.forename: Kelleny
authors.initials: K
authors.lastname: Oum
authors.forename: Raymond
authors.initials: R
authors.lastname: Ro
authors.forename: Dalia
authors.initials: D
authors.lastname: El-Sherif
mesh_terms: D000162:Acoustics; D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry; D003287:Contrast Media / Q000737:chemistry*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007275:Injections, Intravenous; D019344:Lactic Acid / Q000737:chemistry; D008297:Male; D045423:Microbubbles; D008855:Microscopy, Electron, Scanning; D011100:Polyglycolic Acid / Q000737:chemistry; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000737:chemistry; D011817:Rabbits; D013696:Temperature; D018608:Ultrasonography, Doppler / Q000379:methods*
chemical_list: D001672:Biocompatible Materials; D003287:Contrast Media; D011108:Polymers; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid